Christopher P Kiritsy is Director of PIERIS PHARMACEUTICALS, INC.. Currently has a direct ownership of 20,000 shares of PIRS, which is worth approximately $149,400. The most recent transaction as insider was on May 25, 2023, when has been sold 10,000 shares (Common Stock) at a price of $0.85 per share, resulting in proceeds of $8,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $149,400

CHRISTOPHER P KIRITSY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2023
BUY
Open market or private purchase
$8,500 $0.85 p/Share
10,000 Added 33.33%
20,000 Common Stock

Also insider at

HTGM
HTG MOLECULAR DIAGNOSTICS, INC Healthcare
CPK

Christopher P Kiritsy

Director
Tucson, AZ

Track Institutional and Insider Activities on PIRS

Follow PIERIS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PIRS shares.

Notify only if

Insider Trading

Get notified when an Pieris Pharmaceuticals, Inc. insider buys or sells PIRS shares.

Notify only if

News

Receive news related to PIERIS PHARMACEUTICALS, INC.

Track Activities on PIRS